Compounds and compositions for eliciting or enhancing immune reactivity
to HER-2/neu protein are disclosed. The compounds include polypeptides and nucleic
acid molecules encoding such peptides. The compounds may be used for the prevention
or treatment of malignancies in which the HER-2/neu oncogene is associated.